… strategies, and novel systemic therapies including chemotherapy and immunotherapies
are gradually changing the treatment paradigm and prognosis of this recalcitrant cancer. …

… Gallbladder cancer (GC) is a relatively rare but highly lethal neoplasm. We review the …
T3 and T4 are mostly systemic disease, because, for example, accidental intraoperative …

… mortality from gallbladder cancer. Vague symptoms often delay the diagnosis of gallbladder
cancer, … Citation27,Citation28 In a recent systematic review of 340 patients with gallbladder …

… A systematic review of the published medical literature using PubMed and Medline was …
Manuscripts focusing on gallbladder cancer were included in this review, while those dedicated …

… review of more than 2000 patients with gallbladder cancer found that 73.9% of patients
had stones present. Other investigators have found similar results. Most patients (70%–88%) …

… Gallbladder cancer is one of the most lethal carcinomas and continues to pose many
challenges for surgeons. Identifiable risk factors for carcinoma of the gallbladder … A systematic …

… cancers; hence, it is not clear which are driving mutations unique to gallbladder cancer.
Certain mutations are associated with other cancer risk factors; for instance, gallbladder cancer …

… This health technology assessment has focussed on surgical approaches in gallbladder
cancer. Guidelines for the treatment of gallbladder cancer are difficult to state as our knowledge …

… This review includes an update of the worldwide distribution of GC incidence, as well as
a systematic review of published findings on the association between GC risk and gallstones, …

… This review evaluated the surgical outcomes of T1 GB cancer. The evidence is of low quality,
because it was obtained from the reviewed articles, and most studies were case series. No …